Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 82.17B | 78.95B | 92.88B | 142.42B | 96.55B | 64.23B |
Gross Profit | 7.73B | 32.47B | 31.69B | 28.71B | 30.96B | 23.27B |
EBITDA | 27.32B | 22.74B | 18.30B | 18.18B | 13.70B | 14.08B |
Net Income | 7.09B | 7.02B | 3.44B | 5.22B | 3.19B | 3.62B |
Balance Sheet | ||||||
Total Assets | 185.19B | 187.14B | 195.22B | 219.62B | 206.94B | 163.45B |
Cash, Cash Equivalents and Short-Term Investments | 11.51B | 10.92B | 11.33B | 24.79B | 11.02B | 6.37B |
Total Debt | 69.22B | 70.35B | 73.56B | 87.91B | 70.92B | 58.66B |
Total Liabilities | 132.44B | 137.97B | 150.12B | 177.54B | 164.60B | 121.10B |
Stockholders Equity | 37.11B | 33.73B | 25.20B | 28.66B | 29.65B | 28.32B |
Cash Flow | ||||||
Free Cash Flow | 4.36B | 4.29B | 1.85B | -4.57B | -2.13B | 1.96B |
Operating Cash Flow | 12.03B | 13.22B | 14.62B | 8.67B | 10.07B | 11.51B |
Investing Cash Flow | -4.75B | -4.11B | -10.61B | -13.63B | -10.88B | -10.12B |
Financing Cash Flow | -6.83B | -7.99B | -8.36B | 7.37B | 3.78B | -3.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $94.02B | 12.31 | 25.04% | 0.31% | -8.80% | 61.27% | |
80 Outperform | $6.10B | 4.14 | 26.38% | 19.36% | -4.14% | 13.02% | |
74 Outperform | $51.03B | 17.22 | 9.76% | 3.22% | -0.39% | 0.75% | |
67 Neutral | $6.19B | 11.97 | 9.22% | 7.16% | -7.02% | 17.33% | |
67 Neutral | $16.79B | 17.01 | 4.47% | 3.89% | 4.76% | 6.06% | |
64 Neutral | $21.14B | 2,867.59 | 0.47% | 6.43% | 12.40% | -108.27% | |
61 Neutral | $9.52B | 7.30 | 29.79% | 5.09% | -3.22% | 141.11% |